Evidence map›Paper›PMID 42221309›Full record

ArticleClinical and experimental hepatology2026

Potential role of NLRP3 genetic polymorphism and gene expression in differentiating causes of neonatal cholestasis.

Fatma Omar Khalil, Salma Abdel Megeed Nagi, Sally Waheed, Shimaa Saad Elkholy, Hala Ahmed Elrefai Khalil, Shimaa Abdelsattar, Abeer Abd Elfattah Ali Elgazzar, Amany E Elashkar

Abstract read
In one paragraph

Article in Clinical and experimental hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fatma Omar KhalilClinical Microbiology and Immunology Department, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt.
Salma Abdel Megeed NagiPediatric Hepatology, Gastroenterology, and Nutrition Department, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt.
Sally WaheedEpidemiology and Preventive Medicine, National Liver Institute Menoufia University, Shebin El-Kom 32511, Egypt.
Shimaa Saad ElkholyPathology Department, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt.
Hala Ahmed Elrefai KhalilClinical Microbiology and Immunology Department, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt.
Shimaa AbdelsattarClinical Biochemistry and Molecular Diagnostics Department, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt.
Abeer Abd Elfattah Ali ElgazzarClinical Pathology Department, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt.
Amany E ElashkarClinical Pathology Department, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim of the study: It has long been a focus of research to differentiate among the various causes of neonatal cholestasis, particularly biliary atresia (BA) from non-BA. The NOD-like receptor pyrin domain-containing 3 (NLRP3) inflammasome's role in the pathophysiology of BA is becoming increasingly clear. However, animal models served as the foundation for most of this research. As it is important to diagnose BA as early as possible for a favorable prognosis, the current investigation aimed to investigate the function of NLRP3 rs10754558 and Material and methods: The study included 21 patients with BA, 24 patients with neonatal cholestasis due to causes other than BA, and 20 healthy infants as the control group. A clinical evaluation and standard laboratory testing were conducted on each participant. NLRP3 rs10754558 and Results: A significant difference in NLRP3 rs10754558 was observed between the BA and non-BA groups in the general genotype model ( Conclusions: In conclusion, NLRP3 rs10754558 may contribute to non-BA neonatal cholestasis in ways other than by influencing gene expression levels. However, in non-BA patients, NLRP3 expression levels may improve coagulation.

Indexed as

gene expressionneonatal cholestasisNLRP3 genetic polymorphismpattern recognition receptors

Identifiers

PMID42221309
PMCPMC13220240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.